Teza Capital Management LLC Makes New $260,000 Investment in Henry Schein, Inc. $HSIC

Key Points

• Teza Capital Management LLC has invested approximately $260,000 in Henry Schein, Inc., acquiring 3,794 shares of the company's stock.
• Henry Schein reported earnings of $1.10 per share for the last quarter, missing expectations by $0.09, while revenue increased 3.3% year-over-year.
• Analysts' ratings for Henry Schein are mixed, with five recommending a buy and seven issuing a hold, while the average price target is set at $76.67.

Teza Capital Management LLC acquired a new position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 3,794 shares of the company's stock, valued at approximately $260,000.

A number of other large investors have also modified their holdings of HSIC. Investment Management Corp VA ADV acquired a new stake in shares of Henry Schein in the 4th quarter worth about $32,000. Rakuten Securities Inc. acquired a new stake in shares of Henry Schein in the 1st quarter worth about $34,000. Whittier Trust Co. increased its holdings in shares of Henry Schein by 714.3% in the 1st quarter. Whittier Trust Co. now owns 798 shares of the company's stock worth $55,000 after acquiring an additional 700 shares during the period. Quarry LP acquired a new stake in shares of Henry Schein in the 1st quarter worth about $71,000. Finally, UMB Bank n.a. increased its holdings in shares of Henry Schein by 23.2% in the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after acquiring an additional 201 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Price Performance

Shares of NASDAQ:HSIC traded down $0.54 during trading hours on Friday, hitting $69.01. 1,115,039 shares of the company's stock traded hands, compared to its average volume of 1,401,834. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The company's fifty day simple moving average is $69.32 and its two-hundred day simple moving average is $69.44. The company has a market cap of $8.37 billion, a price-to-earnings ratio of 22.26, a price-to-earnings-growth ratio of 2.28 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter last year, the business posted $1.23 EPS. The business's revenue for the quarter was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, equities analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently weighed in on HSIC shares. Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Sunday, September 7th. Robert W. Baird reissued a "neutral" rating and set a $72.00 target price (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. JPMorgan Chase & Co. lowered their target price on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a research note on Thursday, August 7th. Finally, Evercore ISI raised shares of Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 target price on the stock in a research note on Tuesday, August 26th. Five research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $76.67.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.